Volker Lakner

Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial

Helmut Oettle, Hanno Riess, Jens Stieler et al. · Journal of Clinical Oncology · 2014 · 484 citations

Medicine, Oncology, Pharmacology +13

Phase II Study of Capecitabine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancer Pretreated With Anthracyclines or Taxanes

Gerhard Schäller, Ilka Fuchs, Thomas Gonsch et al. · Journal of Clinical Oncology · 2007 · 100 citations · Full text

Medicine, Oncology, Pharmacology +17

Results of a Prospective Randomised Open Label Phase III Study Comparing Rituximab Plus Mitoxantrone, Chlorambucile, Prednisolone Chemotherapy (R-MCP) Versus MCP Alone in Untreated Advanced Indolent Non-Hodgkin’s Lymphoma (NHL) and Mantle-Cell-Lymphoma (MCL).

Michael Herold, R. Pasold, Stefanie Srock et al. · Blood · 2004 · 72 citations

Medicine, Oncology, Pharmacotherapy +13

Fludarabine and Bendamustine in Refractory and Relapsed Indolent Lymphoma—a Multicenter Phase I/II Trial of the East German Society of Hematology and Oncology (OSHO)

Michael Koenigsmann, Wolfgang Knauf, Michael Herold et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2004 · 43 citations

Medicine, Oncology, Pharmacology +16

Diffuse Gastric Antral Vascular Ectasia: Cause of Chronic Gastrointestinal Blood Loss

Thomas Arendt, M Barten, Volker Lakner et al. · Endoscopy · 1987 · 36 citations

Medicine, Anatomy, Pathology +12